Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Gen Zers and millennials see many weight loss drug ads on digital media—many of which contain misleading claims

The trend: Pharma companies are pouring more money each year into digital advertising—a strategy that’s starting to pay off for weight loss drug manufacturers.

  • Younger consumers see ads for weight loss drugs on some digital channels nearly as much or even more than on linear TV, according to EMARKETER’s December 2024 Digital Health Survey of 1,312 US consumers ages 15 to 79.

Digging into the data: Consumers who’ve heard of GLP-1s have seen ads or endorsements for them on a range of media channels. Linear TV (64%) tops the list, per our survey.

You've read 0 of 2 free articles this month.

Create an account for uninterrupted access to select articles.
Create a Free Account